Drugs / FOLITIXORIN

Trials 5

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00663481 Apr → May 2008 — Mast Therapeutics, Inc. Completed No outcome recorded
Phase 23 trials
Phase 2 NCT00434369 Feb 2006 → ? breast cancer Mast Therapeutics, Inc. Unknown No outcome recorded
Phase 2 NCT00235898 May 2005 → Mar 2008 colon carcinoma, rectal carcinoma Mast Therapeutics, Inc. Completed No outcome recorded
Phase 2 NCT00081627 Apr 2004 → Jan 2007 colon carcinoma, rectal carcinoma Mast Therapeutics, Inc. Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00337389 May 2006 → ? rectal cancer Mast Therapeutics, Inc. Unknown No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as FOLITIXORIN ChEMBL registry synonym — accepted as the source's own label CHEMBL117348 ↗
Known as 5,10-methylenetetrafolate ChEMBL registry synonym — accepted as the source's own label CHEMBL117348 ↗
Known as 5-10 Methylenetetrahydrofolate “CoFactor (5-10 Methylenetetrahydrofolate)” NCT00434369 ↗
Known as ANX-510 “CoFactor (ANX-510)” NCT00434369 ↗
1

“CoFactor (ANX-510)” NCT00337389 ↗

Known as CoFactor ClinicalTrials.gov intervention name — accepted as the source's own label NCT00663481 ↗
4

NCT00434369 ↗

NCT00081627 ↗

NCT00337389 ↗

NCT00235898 ↗

Known as FOLITIXORIN CALCIUM ChEMBL registry synonym — accepted as the source's own label CHEMBL117348 ↗
Known as Folitixorina ChEMBL registry synonym — accepted as the source's own label CHEMBL117348 ↗
Known as Folitixorine ChEMBL registry synonym — accepted as the source's own label CHEMBL117348 ↗
Modality Small molecule — CHEMBL117348 ↗
Route Intravenous “CoFactor Formulations and of Leucovorin Administered Intravenously in Healthy, Adult Subjects.” NCT00663481 ↗